Information de reference pour ce titreAccession Number: | 00000434-200702000-00012.
|
Author: | Wolf, Anne T. M.D. 1; Wasan, Sharmeel K. M.D. 2; Saltzman, John R. M.D. 1
|
Institution: | (1)Division of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (2)Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
|
Title: | |
Source: | American Journal of Gastroenterology. 102(2):290-296, February 2007.
|
Abstract: | OBJECTIVE: Endoscopic therapy for nonvariceal upper gastrointestinal hemorrhage achieves hemostasis in greater than 90% of patients, but up to 20% rebleed. The aim of this study was to determine the impact of anticoagulation on rebleeding in patients undergoing endoscopic therapy for nonvariceal upper gastrointestinal hemorrhage.
METHODS: Patients who underwent successful endoscopic therapy for nonvariceal upper gastrointestinal hemorrhage between July 1, 1999, and June 30, 2004, at a large, tertiary care teaching hospital were identified. The primary outcome was rebleeding within 30 days. Secondary outcomes were transfusion requirement, length of stay, surgery, and mortality. Baseline data were analyzed using t-tests and [chi]2 tests. Multivariable logistic and linear regression analyses were carried out to calculate the adjusted odds ratios for the international normalized ratio (INR) predicting the primary and secondary outcomes. The multivariable analyses controlled for: age, Charlson comorbidity index, antiplatelet agent use, postprocedure heparin use, postprocedure proton pump inhibitor use, hypotension, ulcer as the bleeding source, and active bleeding at endoscopy.
RESULTS: The study included 233 patients. Forty-four percent of the patients had an INR >=1.3. Ninety-five percent of the anticoagulated patients had an INR between 1.3 and 2.7. The rebleeding rate was 23% in the anticoagulated patients and 21% in the patients with INRs <1.3. On multivariable analyses, INR was not a predictor of rebleeding, transfusion requirement, surgery, length of stay, or mortality.
CONCLUSIONS: Mild to moderate anticoagulation does not increase the risk of rebleeding following endoscopic therapy for nonvariceal upper gastrointestinal hemorrhage, suggesting that endoscopic therapy is appropriate in these patients.
(C) The American College of Gastroenterology 2007. All Rights Reserved.
|
References: | 1. Conrad S. Acute upper gastrointestinal bleeding in critically ill patients: Causes and treatment modalities. Crit Care Med 2002;30(suppl):S365-8.
2. Barkun A, Bardou M, Marshall J. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2003;139:843-57.
3. Gitter MJ, Jaeger TM, Petterson TM, et al. Bleeding and thromboembolism during anticoagulant therapy: A population-based study in Rochester, Minnesota. Mayo Clin Proc 1995;70:725-33.
4. Kaplan RC, Heckbert SR, Koepsell TD, et al. Risk factors for hospitalized gastrointestinal bleeding among older persons. J Am Geriatr Soc 2001;49:126-33.
5. Younossi ZM, Strum WB, Schatz RA, et al. Effect of combined anticoagulation and low-dose aspirin treatment on upper gastrointestinal bleeding. Dig Dis Sci 1997;42:79-82.
6. Johnsen SP, Sorensen HT, Mellemkjoer L, et al. Hospitalization for upper gastrointestinal bleeding associated with use of oral anticoagulants. Thromb Haemost 2001;86:563-8.
7. Laine L, Peterson W. Medical progress: Bleeding peptic ulcer. N Engl J Med 1994;331:717-27.
8. Thomopoulos KC, Mimidis KP, Theocharis GJ, et al. Acute upper gastrointestinal bleeding in patients on long-term oral anticoagulation therapy: Endoscopic findings, clinical management and outcome. World J Gastroenterol 2005;11:1365-8.
9. Lin HJ, Lo WC, Lee FY, et al. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med 1998;158:54-8.
10. Lau JY, Sung JJ, Lee KK, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000;343:310-6.
11. Javid G, Masoodi I, Zagar SA, et al. Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. Am J Med 2001;111:280-4.
12. Kaviani MJ, Hashemi MR, Kazemifar AR, et al. Effect of oral omeprazole in reducing re-bleeding in bleeding peptic ulcers: A prospective, double-blind, randomized, clinical trial. Aliment Pharmacol Ther 2003;17:211-6.
13. Leontiadis GI, Sharma VK, Howeden CW. Systemic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding. BMJ 2005;300:568-75.
14. Andruilli A, Annese V, Cruso N, et al. Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcer: A series of meta-analyses. Am J Gastroenterol 2005;100:207-19.
15. Udd M, Miettinen P, Palmu A, et al. Regular-dose versus high dose omeprazole in peptic ulcer bleeding. Scand J Gastroenterol 2001;36:1332-8.
16. Lin HJ, Lo WC, Chen YC, et al. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: A prospective randomized comparative trial. Am J Gastroenterol 2006;101:500-5.
17. Wong SKH, Lau JYW, Lam Y-H, et al. Prediction of therapeutic failure after adrenaline injection plus heater probe treatment in patients with bleeding peptic ulcer. Gut 2002;50:322-55.
18. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373-83.
19. Kollef MH, O'Brien JD, Zuckerman GR, et al. BLEED: A classification tool to predict outcomes in patients with acute upper and lower gastrointestinal hemorrhage. Crit Care Med 1997;25:1125-32.
20. Rubin T, Murdoch M, Nelson D. Acute GI bleeding in the setting of supratherapeutic international normalized ratio in patients taking warfarin: Endoscopic diagnosis, clinical management and outcomes. Gastrointest Endosc 2003;58:369-73.
|
Language: | English.
|
Document Type: | ORIGINAL CONTRIBUTION: ENDOSCOPY/PANCREAS.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0002-9270
|
NLM Journal Code: | 3he, 0421030
|
Annotation(s) | |
|
|